LUMINA
What if a blood sample could help predict how lung cancer will develop and respond to treatment? LUMINA aims to turn this possibility into reality through AI-powered digital twins for more precise and personalised cancer care.
In LUMINA, we develop personalised digital twins that combine clinical data, medical imaging, pathology and blood-based biomarkers.
By modelling disease progression and treatment response, these AI-powered representations will help clinicians anticipate risks, compare treatment options and make more informed decisions.
KEY INNOVATIONS

We transform lung cancer care through AI-powered digital twins
LUMINA aims to advance predictive, personalised lung cancer care and create technologies that could eventually be adapted to other cancers.


Partners




